However, under the current WHO classification, GBM is strictly defined as IDH-wildtype, and IDH-mutant high-grade gliomas are now classified separately as astrocytoma, IDH-mutant, Grades II-IV. The gene discussed is IDH1; the disease is central nervous system cancer.